Director in Apollomics (APLM) reports 2,000 restricted stock units on Form 3
Filing Impact
Filing Sentiment
Form Type
3
Rhea-AI Filing Summary
Apollomics Inc. director TSAI HSIEN-SHU reported an initial holding of restricted stock units that are linked to the company’s Class A Ordinary Shares. The position covers restricted stock units tied to 2,000 underlying Class A Ordinary Shares held directly.
According to the footnotes, these restricted stock units vested with respect to 500 shares upon grant on February 9, 2026, with an additional 500 shares scheduled to vest on each of March 15, 2026, June 15, 2026 and September 15, 2026. Each unit represents a contingent right to receive one Class A Ordinary Share.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
TSAI HSIEN-SHU
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Restricted Stock Units | -- | -- | -- |
Holdings After Transaction:
Restricted Stock Units — 2,000 shares (Direct)
Footnotes (1)
- The restricted stock units were vested with respect to 500 shares upon grant on February 9, 2026, with an additional 500 shares vesting on each of March 15, 2026, June 15, 2026 and September 15, 2026. Each restricted stock unit represents a contingent right to receive one Class A Ordinary Share.
FAQ
What insider position did TSAI HSIEN-SHU report in Apollomics (APLM) Form 3?
TSAI HSIEN-SHU reported holding restricted stock units tied to 2,000 Apollomics Class A Ordinary Shares. These units reflect equity-based compensation and are held directly, giving the director contingent rights to receive company shares as they vest over time.
What is the vesting schedule of the Apollomics (APLM) restricted stock units?
The units vested with respect to 500 shares on February 9, 2026, the grant date. Additional tranches of 500 shares vest on March 15, 2026, June 15, 2026 and September 15, 2026, creating four equal installments across the vesting period.
Is the Apollomics (APLM) Form 3 filing a buy or sell transaction?
The Form 3 reflects an initial statement of beneficial ownership, not an open-market buy or sell. It records an existing equity award of restricted stock units and their vesting schedule rather than a new purchase or sale of Apollomics shares.
What type of security is reported in the Apollomics (APLM) Form 3?
The security reported is restricted stock units, each linked to one Class A Ordinary Share. These units are a form of equity compensation that convert into actual shares over time, according to the specified vesting dates in the award’s terms.